TMS and Dementia: Can a “Magnet for the Brain” Help?

Scroll to explore
HIPPA logo
HIPAA
Compliant

If you’ve ever stuck a fridge magnet on a grocery list and thought, “Wow, this is powerful technology,” you’re already emotionally prepared for transcranial magnetic stimulation (TMS). The difference is TMS isn’t trying to keep your TO DO list from flying away… it’s could be a tool that helps keep your entire memory intact.

Dementia is one of the most challenging diagnoses for patients, families, and clinicians. It affects memory, thinking, behavior, and daily functioning, and it rarely comes in a package by itself. Sleep disruption, depression, anxiety, and caregiver burnout often show up too. While today’s dementia medications can help some symptoms for some people, there’s an ongoing search for complementary, non-drug tools that may support cognition and quality of life.

One option being actively studied: repetitive TMS (rTMS).

What is TMS?

Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique that uses magnetic impulses to stimulate the brain. It doesn’t require medications, surgery, implants, or anesthesia, making it safe for people with other health problems or complicated medication regimens. It’s not like the Electroconvulsive Therapy (ECT) most people picture when they think of a brain stimulating device. That requires an OR and sedation and uses electricity. The magnets of TMS feel like a tapping on the scalp, but that magnetic impulse is enough to wake up some sleepier parts of the brain and get them firing a little better.

There are different “flavors” of TMS, but the one most often discussed in research is repetitive TMS (rTMS), meaning pulses are delivered in patterned trains over several minutes. Another commonly discussed variant is theta burst stimulation (TBS), which uses shorter bursts designed to mimic natural brain rhythms.

How does TMS work in general?

Think of the brain as a collection of interconnected networks that communicate using electrical activity and chemical signaling. In many brain conditions, the issue isn’t just “a damaged spot”… it’s how networks actually talk to each other.

rTMS can influence this network communication by changing cortical excitability (how “ready” a region is to fire) and encouraging plasticity (the brain’s ability to adapt). Very broadly:

  • Higher-frequency rTMS (often ≥5 Hz) tends to increase excitability in targeted circuits.
  • Lower-frequency rTMS (often ≤1 Hz) tends to reduce excitability.
  • Patterned protocols (like TBS) aim to steer plasticity efficiently.

In research settings, repeated sessions can produce effects that outlast the stimulation period, suggesting changes in learning-like processes in the brain. A helpful way to imagine it: rTMS is less like “turning the brain on,” and more like adjusting the gain on specific network pathways.

Why TMS for neurological disease?

Neurological diseases often involve:

  • disrupted network connectivity (communication problems),
  • altered excitability (too much or too little activity in key circuits),
  • and impaired plasticity (difficulty adapting).

TMS is interesting because it’s targetable (you can stimulate specific cortical regions) and repeatable (daily sessions over weeks), and it can be paired with rehab or cognitive training to potentially strengthen beneficial network patterns.

That pairing idea matters: if rehabilitation is the practice, TMS may be a way to help the brain’s “practice mode” engage more effectively.

TMS for Dementia and Alzheimer’s: What’s the rationale?

Most dementia-related TMS research focuses on Alzheimer’s disease (AD) and mild cognitive impairment (MCI)(often considered a risk state for dementia). Many studies target regions involved in attention, executive function, and memory networks, commonly the dorsolateral prefrontal cortex (DLPFC) and other network hubs.

In Alzheimer’s and related dementias, the brain’s communication highways can become inefficient. Some hubs are underactive, some are out of sync, and the system compensates until it can’t. rTMS is being studied as a way to:

  • enhance activity in underperforming cognitive networks,
  • improve connectivity between regions,
  • and potentially support cognitive performance (often measured with tests like ADAS-Cog, MMSE, or other neuropsych measures).

What do studies show?

The evidence isn’t “case closed,” but it is active and increasingly detailed.

  • large multisite double-blind randomized trial investigated rTMS in people with mild-to-moderate Alzheimer’s disease, comparing different treatment durations and sham stimulation. This kind of study design is important because it tests whether improvements exceed placebo effects in a controlled way. 
  • systematic review published in 2024 evaluated rTMS for Alzheimer’s disease by summarizing findings from multiple systematic reviews and meta-analyses, reflecting a broader attempt to reconcile mixed results across trials. 
  • meta-analysis examined randomized controlled trials of rTMS in Alzheimer’s and discussed both potential benefits and the limits of then-available data. 
  • A comparative review looked at cognitive effects and acceptability of non-invasive brain stimulation approaches (including rTMS) in Alzheimer’s and MCI, and also explored whether combining stimulation with cognitive training adds benefit. 
  • For MCI, sham-controlled randomized work has examined whether rTMS can improve aspects of cognition like working memory, an area of particular interest because intervening earlier (before dementia) may be more feasible than reversing later-stage decline. 
  • Newer protocols continue to be explored, like a 2025 study exploring intermittent theta burst stimulation (iTBS) protocols aimed at memory outcomes in MCI. Studies like this point to the value of past research and the direction of future investigations.

What does this mean for patients today?

If you’re looking for an honest summary: rTMS for dementia is promising, but not uniformly proven. Results vary based on:

  • dementia stage and type,
  • which brain region is targeted,
  • stimulation frequency/intensity,
  • number of sessions,
  • and whether cognitive training is paired with stimulation.

In practical terms, some research suggests measurable cognitive improvements in some groups, while other studies show smaller or inconsistent effects. The research is encouraging, but the field is still answering key questions like: Which patients benefit most? What protocol works best? How durable are the improvements?

In other words, we’re not at “TMS is magic eraser for dementia,” but we may be closer to “TMS can be a helpful tool in a broader care plan,” which, honestly, is how most real medicine works.

Other neurological conditions where TMS may help

Even though dementia gets a lot of headlines, TMS research has been expanding across neurology for years.

Parkinson’s disease

Parkinson’s disease (PD) is primarily known for motor symptoms (tremor, rigidity, slowness), but it also affects mood and cognition. Meta-analytic evidence suggests rTMS can improve motor symptoms in PD, with effects influenced by stimulation site, frequency, and dose.

rTMS isn’t a replacement for PD medications or deep brain stimulation, but the research suggests it may be a useful adjunct for certain symptoms in certain patients, especially within structured protocols.

Stroke recovery

After stroke, the brain can become imbalanced, meaning one hemisphere may be underactive while the other “overcompensates.” rTMS is being studied as a way to restore healthier interhemispheric dynamics and support rehabilitation.

  • 2025 systematic review and meta-analysis evaluated rTMS for motor function in stroke patients, focusing on randomized controlled evidence. 
  • systematic review and meta-analysis published in 2024 looked specifically at rTMS and motor recovery after stroke with attention to trial quality and stimulation nuances. 
  • A more recent review examined navigated rTMS added to standard rehab for post-stroke upper limb outcomes, highlighting the trend toward more individualized targeting. 
  • Another meta-analysis addressed rTMS effects on lower-limb motor function after stroke. 

Rehabilitative therapies, like occupational therapy, speech therapy, and physical therapy, are the pillars of stroke recovery, but when integrated into post-stroke treatment plans, rTMS appears to help the brain be more “trainable” during therapy.

So… should we be excited about TMS for dementia?

Yes! With calm excitement… and more patience than anyone who has or loves someone with cognitive losses probably has.

Here’s a grounded way to frame it:

  • What we know: rTMS can modulate brain activity and plasticity; multiple studies and meta-analyses report cognitive improvements in Alzheimer’s/MCI cohorts, with acceptable tolerability. 
  • What we’re still learning: optimal protocols, best targets, durability of gains, and which dementia subtypes/stages respond best, plus how to combine rTMS with cognitive training or lifestyle interventions for maximum benefit. 

For families navigating dementia, even small improvements, such as better attention, steadier mood, slightly easier communication, can meaningfully change daily life. If ongoing research can clarify who benefits and how to deliver treatment most effectively, TMS could become a more common part of comprehensive dementia care.

Get well sooner

Don't spend another second wondering if life has to be this hard.
Find the help and support you need at bonmente.
Get started

Most relevant posts

TMS
TMS for Migraines: Hitting the Brain "Reset" Button

Wait, the thing used for depression can help my migraines? Yep. Learn how.